PE20091235A1 - Composiciones que comprenden acido asiatico y/o acido madecasico - Google Patents

Composiciones que comprenden acido asiatico y/o acido madecasico

Info

Publication number
PE20091235A1
PE20091235A1 PE2008001970A PE2008001970A PE20091235A1 PE 20091235 A1 PE20091235 A1 PE 20091235A1 PE 2008001970 A PE2008001970 A PE 2008001970A PE 2008001970 A PE2008001970 A PE 2008001970A PE 20091235 A1 PE20091235 A1 PE 20091235A1
Authority
PE
Peru
Prior art keywords
acid
madecasic
compositions including
including asian
centella asiatica
Prior art date
Application number
PE2008001970A
Other languages
English (en)
Inventor
Caroline Segond
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of PE20091235A1 publication Critical patent/PE20091235A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Abstract

REFERIDA UNA COMPOSICION FARMACEUTICA TOPICA U ORAL QUE COMPRENDE ACIDO ASIATICO Y/O ACIDO MADECASICO O UN EXTRACTO DE CENTELLA ASIATICA QUE COMPRENDE UNO O AMBOS ACIDOS, DONDE EL ACIDO ASIATICO Y/O ACIDO MADECASICO SE ENCUENTRAN EN UNA CANTIDAD DE ENTRE 0,005% A 10% EN PESO DE LA COMPOSICION TOTAL. DICHOS COMPUESTOS DE LA CENTELLA ASIATICA INHIBEN LA GLUCACION Y SON UTILES EN EL TRATAMIENTO DE SINTOMAS DE ENVEJECIMIENTO DE LA PIEL, UNAS Y CABELLO, CAPILARITIS, ESCLEROSIS, ENTRE OTRAS
PE2008001970A 2007-12-06 2008-11-25 Composiciones que comprenden acido asiatico y/o acido madecasico PE20091235A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07291467 2007-12-06

Publications (1)

Publication Number Publication Date
PE20091235A1 true PE20091235A1 (es) 2009-08-22

Family

ID=40148632

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001970A PE20091235A1 (es) 2007-12-06 2008-11-25 Composiciones que comprenden acido asiatico y/o acido madecasico

Country Status (6)

Country Link
EP (1) EP2229165A1 (es)
AR (1) AR069518A1 (es)
CL (1) CL2008003505A1 (es)
PE (1) PE20091235A1 (es)
TW (1) TW200938215A (es)
WO (1) WO2009071213A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102044562B1 (ko) 2011-05-10 2019-11-13 마리 케이 인코포레이티드 화장 조성물
WO2014095289A2 (en) * 2012-12-20 2014-06-26 Unilever Plc Method of treating hair ageing
GB2543091A (en) * 2015-10-09 2017-04-12 Carlene Weller Kerri-Anne A topical herbal healing formulation
US10980851B2 (en) * 2018-06-08 2021-04-20 The Procter & Gamble Company Topical skincare compositions comprising Centella asiatica selected triterpenes
CN111920760B (zh) * 2020-07-28 2024-02-27 长沙医学院 一种羟基积雪草酸固体脂质纳米粒凝胶

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1133417C (zh) * 1996-04-23 2004-01-07 普罗克特和甘保尔公司 维生素b3化合物调节皮肤外观的方法
JP3657068B2 (ja) * 1996-12-03 2005-06-08 ポーラ化成工業株式会社 光老化防止改善剤および皮膚外用剤
IT1312089B1 (it) * 1999-04-21 2002-04-04 Euphar Group Srl Sali dell'acido asiatico e medacassico atti alla preparazione dicomposizioni farmaceutiche e cosmetiche.
AU7651100A (en) * 1999-09-15 2001-04-17 Roche Consumer Health Ag Pharmaceutical and/or cosmetical compositions
ITMI20011022A1 (it) * 2001-05-17 2002-11-17 Indena Spa Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo

Also Published As

Publication number Publication date
TW200938215A (en) 2009-09-16
EP2229165A1 (en) 2010-09-22
WO2009071213A1 (en) 2009-06-11
CL2008003505A1 (es) 2009-06-12
AR069518A1 (es) 2010-01-27

Similar Documents

Publication Publication Date Title
BRPI0910874B8 (pt) formulação tópica para uso no tratamento tópico de uma condição da pele que resulta da produção de espécies reativas de oxigênio e/ou para a promoção da cicatrização de ferida tópica na pele de um indivíduo e uso da referida formulação
ES2721148T3 (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
BRPI1007945B8 (pt) formulação farmacêutica de liberação controlada de nitazoxamida, tizoxanida ou uma combinação dos mesmos, e, comprimido de bicamada para administração oral
UA102478C2 (en) Capsule composition
EA201001555A1 (ru) Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17
AR052847A1 (es) Composiciones con oregano para el cuidado bucal y metodos para su utilizacion
NI201100081A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa - iv para el tratamiento o prevención de diabetes.
PE20091235A1 (es) Composiciones que comprenden acido asiatico y/o acido madecasico
CO6321221A2 (es) Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
CL2012001217A1 (es) Composicion farmaceutica de aplicacion topica que comprende al menos un mejorador de la penetracion y 0,1 a 30% p/p de bimatoprost; kit que comprende la composicion; y uso para estimular el crecimiento del cabello en enfermedades tales como alopecia areata y tinea capitis, entre otras.
CL2011002858A1 (es) Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor.
BR112015001313A2 (pt) composições de vacina
UA99101C2 (ru) Композиция для местного ухода за кожей, содержащая соединения глицерина ди- и моносалицилата
EA201170289A1 (ru) Фармацевтические композиции и способы их получения при низкой концентрации примесей
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
MX2009010989A (es) Composiciones farmaceuticas liofilizadas y metodos de obtener y usar las mismas.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
DE602007002553D1 (de) Ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung
CL2011001777A1 (es) Composicion farmaceutica que contiene aleglitazar; proceso para preparar dicha composicion farmaceutica; y su uso para el tratamiento o profilaxis de la diabetes tipo ii o enfermedades cardiovasculares.
ECSP088408A (es) Composiciones farmacéuticas que comprenden combinaciones de analgésicos y anticonvulsivantes para el tratamiento del dolor agudo y crónico
IN2011KN05169A (es)
TR201903470T4 (tr) Kişisel hijyen için formülasyon.
BR112015027436A8 (pt) composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos
BR112015006959A2 (pt) Uso cosmético, processo cosmético e conjunto
CL2007003318A1 (es) Compuestos derivados de 4,5-difenil-pirrol-2-carboxamida; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento o la prevencion de enfermedades tales como sindrome de abstinencia a una sustancia, t

Legal Events

Date Code Title Description
FA Abandonment or withdrawal